<SEC-DOCUMENT>0001607062-19-000052-index.html : 20190130
<SEC-HEADER>0001607062-19-000052.hdr.sgml : 20190130
<ACCEPTANCE-DATETIME>20190130172719
ACCESSION NUMBER:		0001607062-19-000052
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20190125
ITEM INFORMATION:		Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
FILED AS OF DATE:		20190130
DATE AS OF CHANGE:		20190130

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GENEREX BIOTECHNOLOGY CORP
		CENTRAL INDEX KEY:			0001059784
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				820490211
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0731

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-25169
		FILM NUMBER:		19552953

	BUSINESS ADDRESS:	
		STREET 1:		10102 USA TODAY WAY
		CITY:			MIRAMAR
		STATE:			FL
		ZIP:			33025
		BUSINESS PHONE:		416-364-2551

	MAIL ADDRESS:	
		STREET 1:		10102 USA TODAY WAY
		CITY:			MIRAMAR
		STATE:			FL
		ZIP:			33025
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>gnbt013019form8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
Document 1 - file: gnbt013019form8k.htm

</DOCUMENT>
</SEC-DOCUMENT>